IRF1 and type 2 diabetes mellitus: Additionally, individuals with both type 2 diabetes (T2D) and PD exhibit increased levels of the pro-inflammatory transcription factors STAT1 and IRF1 along with a decrease in JMJD3 expression in circulating monocytes [151].